In this expert interview, Deepak L. Bhatt, MD, MPH discusses guideline-based and emerging strategies for reducing recurrent ischemic stroke risk. From dietary interventions and blood pressure control to...
A randomized phase 3 trial evaluated cebranopadol, a dual-NMR agonist, for postoperative pain after abdominoplasty and found reduced pain and opioid use. This study was presented on May 1, 2025, at the ASRA...
A recent presentation at the American College of Physicians Internal Medicine Meeting 2025 highlighted updated approaches to inpatient diabetes management.
A study presented at the American College of Cardiology's 74th Annual Scientific Session found that GLP-1RA use in patients with psoriasis was linked to a lower incidence of major adverse cardiovascular...
A real-world retrospective study found that adding GLP-1 receptor agonists to hormone therapy may reduce endometrial cancer risk in women with benign uterine or endometrial hyperplasia. This study was...
A randomized clinical trial found that while low-magnitude mechanical signals did not improve trabecular bone mineral density in adolescents with anorexia nervosa, it significantly increased tibial bone...
A clinical trial suggests semaglutide significantly reduces abdominal fat in HIV-associated lipohypertrophy, but the potential for adverse events warrant further investigation.
In a recent randomized, double-blind, placebo-controlled study, researchers found reductions in both body weight and knee pain in individuals with obesity and knee osteoarthritis following weekly treatment...
Individuals with prediabetes who achieve a weight loss of at least 5% experience significant improvements in insulin sensitivity and reductions in visceral fat, suggesting that remission of prediabetes can...
